Press Release

Innovative Research by Meticulous Research® Foresees Global Epigenetics Market Surge to $5.47 Billion by 2030

Meticulous Research®, a distinguished global market research firm, has unveiled its latest research report titled 'Epigenetics Market,' providing profound insights into the industry. Anticipating a robust growth trajectory, the global epigenetics market is projected to reach an impressive $5.47 billion by 2030, boasting a compelling Compound Annual Growth Rate (CAGR) of 15.7%.

Driving Factors

The report identifies key factors propelling market growth, including the escalating incidence of chronic diseases driven by an aging population, a surge in cancer prevalence, increased pharmaceutical Research & Development (R&D) expenditures, growing emphasis on epigenetics in drug discovery and development, and the declining costs of genome sequencing. Despite these promising indicators, the market faces challenges attributed to a shortage of skilled professionals.

Growth Opportunities and Challenges

The report highlights growth opportunities arising from expanding applications of epigenetics in non-oncology diseases and government initiatives supporting large-scale genomic sequencing projects. However, it acknowledges challenges related to standardization concerns in epigenetics procedures and limited applications of epigenetics in toxicology.

Key Players Shaping the Landscape

Prominent industry players influencing the global epigenetics market include Thermo Fisher Scientific Inc., Merck KGaA, Illumina, Inc., QIAGEN N.V., and other leading organizations. These key players play a pivotal role in shaping the landscape through innovation and cutting-edge advancements.

Market Segmentation

The report meticulously segments the market based on offerings, methods, applications, and end-users. Notably, in 2023, the kits & reagents segment is predicted to dominate, with the kits & assays sub-segment expected to exhibit the highest growth. DNA methylation emerges as a leading method, particularly high-resolution melt (HRM) analysis, showcasing substantial growth potential.

Insights into Applications

In 2023, the oncology segment is poised to capture the largest market share, fueled by global cancer burdens and concerted government efforts in cancer research and treatment. The report emphasizes the pivotal role of epigenetics in differentiating nuclear organization, DNA methylation, and histone modification patterns between cancer and normal cells.

Geographical Trends

Asia-Pacific stands out as the region with the highest projected Compound Annual Growth Rate (CAGR) during the forecast period, driven by government initiatives, rising cancer incidences, a growing geriatric population, increased Research & Development (R&D) spending, and escalating healthcare expenditures.

Download the Full Report

For a comprehensive analysis and insights into the global epigenetics market, interested parties can download the sample report here.

Contact Information

For further inquiries, contact Meticulous Research® via email at [email protected] or call +1-646-781-8004. Connect on LinkedIn here.

About Meticulous Research®

Meticulous Research® is a globally recognized market research firm renowned for delivering comprehensive and insightful reports, empowering businesses to make informed decisions.